Error message

No crossref credentials set for jcb

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

J. Cell Biol., 8 November 2004
Vol. 167, Issue 3, p. 469-478
DOI: 10.1083/jcb.200403155

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone

  1. Christopher C. Williams1,
  2. June G. Allison6,
  3. Gregory A. Vidal2,
  4. Matthew E. Burow3,
  5. Barbara S. Beckman4,
  6. Luis Marrero5, and
  7. Frank E. Jones1
  1. 1Department of Biochemistry, Tulane University Health Sciences Center, Tulane Cancer Center
  2. 2Department of Structural and Cellular Biology, Tulane University Health Sciences Center, Tulane Cancer Center
  3. 3Department of Medicine, Tulane University Health Sciences Center, Tulane Cancer Center
  4. 4Department of Pharmacology, Tulane University Health Sciences Center, Tulane Cancer Center
  5. 5Louisiana State University Health Sciences Center, Gene Therapy Program, The Morphology and Imaging Core Laboratory, New Orleans, LA 70112
  6. 6Northshore High School, Saint Tammany School Board, Slidell, LA 70461
  1. Correspondence to Frank E. Jones: fjones{at}tulane.edu

Abstract

In the lactating breast, ERBB4 localizes to the nuclei of secretory epithelium while regulating activities of the signal transducer and activator of transcription (STAT) 5A transcription factor essential for milk-gene expression. We have identified an intrinsic ERBB4 NLS (residues 676–684) within the ERBB4 intracellular domain (4ICD) that is essential for nuclear accumulation of 4ICD. To determine the functional significance of 4ICD nuclear translocation in a physiologically relevant system, we have demonstrated that cotransfection of ERBB4 and STAT5A in a human breast cancer cell line stimulates β-casein promoter activity. Significantly, nuclear localization of STAT5A and subsequent stimulation of the β-casein promoter requires nuclear translocation of 4ICD. Moreover, 4ICD and STAT5A colocalize within nuclei of heregulin β1 (HRG)-stimulated cells and both proteins bind to the endogenous β-casein promoter in T47D breast cancer cells. Together, our results establish a novel molecular mechanism of transmembrane receptor signal transduction involving nuclear cotranslocation of the receptor intracellular domain and associated transcription factor. Subsequent binding of the two proteins at transcription factor target promoters results in activation of gene expression.

  • Submitted: 29 March 2004
  • Accepted: 23 September 2004

Citation:

C. C. Williams, J. G. Allison, G. A. Vidal, M. E. Burow, B. S. Beckman, L. Marrero, and F. E. Jones, The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478 (2004).

Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles
V. Fock, K. Plessl, R. Fuchs, S. Dekan, S. K. Milla, S. Haider, C. Fiala, M. Knofler, and J. Pollheimer
Hum Reprod 30, 789-799 (1 April 2015)

Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
J. W. Haskins, D. X. Nguyen, and D. F. Stern
Sci Signal 7, ra116-ra116 (9 December 2014)

Hypoxia-inducible Factor-1{alpha} Induces ErbB4 Signaling in the Differentiating Mammary Gland
I. Paatero, T. N. Seagroves, K. Vaparanta, W. Han, F. E. Jones, R. S. Johnson, and K. Elenius
J Biol Chem 289, 22459-22469 (8 August 2014)

Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells
V. B. Wali, J. W. Haskins, M. Gilmore-Hebert, J. T. Platt, Z. Liu, and D. F. Stern
Mol Cancer Res 12, 1140-1155 (1 August 2014)

Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors
C. V. Ichim, J. W. Haskins, M. Gilmore-Hebert, J. T. Platt, Z. Liu, and D. F. Stern
Stem Cells Trans Med 3, 405-415 (1 April 2014)

Receptor Tyrosine Kinases in the Nucleus
G. Carpenter, and H.-J. Liao
Cold Spring Harb. Perspect. Biol. 5, a008979-a008979 (1 October 2013)

Biological Function of Nuclear Receptor Tyrosine Kinase Action
S. Song, K. M. Rosen, and G. Corfas
Cold Spring Harb. Perspect. Biol. 5, a009001-a009001 (1 July 2013)

Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src
K. Ishibashi, Y. Fukumoto, H. Hasegawa, K. Abe, S. Kubota, K. Aoyama, S. Kubota, Y. Nakayama, and N. Yamaguchi
J. Cell Sci. 126, 625-637 (15 January 2013)

Cell Responses to Growth Factors: The Role of Receptor Tyrosine Kinase Intracellular Domain Fragments
G. Carpenter, and A. Pozzi
Sci Signal 5, pe42-pe42 (25 September 2012)

Protein Inhibitor of Activated STAT3 (PIAS3) Protein Promotes SUMOylation and Nuclear Sequestration of the Intracellular Domain of ErbB4 Protein
M. Sundvall, A. Korhonen, K. Vaparanta, J. Anckar, K. Halkilahti, Z. Salah, R. I. Aqeilan, J. J. Palvimo, L. Sistonen, K. Elenius et al.
J Biol Chem 287, 23216-23226 (29 June 2012)

Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1{alpha} Signaling
I. Paatero, A. Jokilammi, P. T. Heikkinen, K. Iljin, O.-P. Kallioniemi, F. E. Jones, P. M. Jaakkola, and K. Elenius
J Biol Chem 287, 9659-9671 (23 March 2012)

Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e
D. Mitra, P. M. Das, F. C. Huynh, and F. E. Jones
J Biol Chem 286, 40531-40535 (25 November 2011)

Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3
C. R. Degnin, M. B. Laederich, and W. A. Horton
Mol. Biol. Cell 22, 3861-3873 (15 October 2011)

Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands
S. Higashiyama, D. Nanba, H. Nakayama, H. Inoue, and S. Fukuda
J Biochem 150, 15-22 (1 July 2011)

Interactions of ErbB4 and Kap1 Connect the Growth Factor and DNA Damage Response Pathways
M. Gilmore-Hebert, R. Ramabhadran, and D. F. Stern
Mol Cancer Res 8, 1388-1398 (1 October 2010)

PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development
C.-B. Chan, X. Liu, M. A. Ensslin, D. L. Dillehay, C. J. Ormandy, P. Sohn, R. Serra, and K. Ye
EMBO J. 29, 956-968 (2 June 2010)

Presenilin/{gamma}-Secretase Cleaves CD46 in Response to Neisseria Infection
N. J. Weyand, C. M. Calton, D. L. Higashi, K. J. Kanack, and M. So
J. Immunol. 184, 694-701 (15 January 2010)

Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
S.-C. Wang, and M.-C. Hung
Clin. Cancer Res. 15, 6484-6489 (1 November 2009)

ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
R. S. Muraoka-Cook, M. A. Sandahl, K. E. Strunk, L. C. Miraglia, C. Husted, D. M. Hunter, K. Elenius, L. A. Chodosh, and H. S. Earp
Mol. Cell. Biol. 29, 4935-4948 (15 September 2009)

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
D. Mitra, M. J. Brumlik, S. U. Okamgba, Y. Zhu, T. T. Duplessis, J. G. Parvani, S. M. Lesko, E. Brogi, and F. E. Jones
Molecular Cancer Therapeutics 8, 2152-2162 (1 August 2009)

Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia
J. Wong, and C. S. Weickert
J Biol Chem 284, 18824-18832 (10 July 2009)

A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
K. Pedersen, P.-D. Angelini, S. Laos, A. Bach-Faig, M. P. Cunningham, C. Ferrer-Ramon, A. Luque-Garcia, J. Garcia-Castillo, J. L. Parra-Palau, M. Scaltriti et al.
Mol. Cell. Biol. 29, 3319-3331 (15 June 2009)

Somatic Mutations of ErbB4: SELECTIVE LOSS-OF-FUNCTION PHENOTYPE AFFECTING SIGNAL TRANSDUCTION PATHWAYS IN CANCER
D. Tvorogov, M. Sundvall, K. Kurppa, M. Hollmen, S. Repo, M. S. Johnson, and K. Elenius
J Biol Chem 284, 5582-5591 (27 February 2009)

The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation
S.-M. Feng, R. S. Muraoka-Cook, D. Hunter, M. A. Sandahl, L. S. Caskey, K. Miyazawa, A. Atfi, and H. S. Earp
Mol. Cell. Biol. 29, 892-906 (1 February 2009)

All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
R.-H. Tao, and I. N. Maruyama
J. Cell Sci. 121, 3207-3217 (1 October 2008)

The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
A. Naresh, A. D. Thor, S. M. Edgerton, K. C. Torkko, R. Kumar, and F. E. Jones
Cancer Res. 68, 6387-6395 (1 August 2008)

ErbB4 Isoforms Selectively Regulate Growth Factor induced Madin-Darby Canine Kidney Cell Tubulogenesis
F. Zeng, M.-Z. Zhang, A. B. Singh, R. Zent, and R. C. Harris
Mol. Biol. Cell 18, 4446-4456 (1 November 2007)

Association of Wwox with ErbB4 in Breast Cancer
R. I. Aqeilan, V. Donati, E. Gaudio, M. S. Nicoloso, M. Sundvall, A. Korhonen, J. Lundin, J. Isola, M. Sudol, H. Joensuu et al.
Cancer Res. 67, 9330-9336 (1 October 2007)

The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation
J. Omerovic, L. Santangelo, E. M.-R. Puggioni, J. Marrocco, C. Dall'Armi, C. Palumbo, F. Belleudi, L. Di Marcotullio, L. Frati, M.-R. Torrisi et al.
FASEB J. 21, 2849-2862 (1 September 2007)

Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia
C. T. Charalambous, A. Hannigan, P. Tsimbouri, G. M. McPhee, and J. B. Wilson
Carcinogenesis 28, 1839-1848 (1 August 2007)

Matrix Metalloproteinase 7 Mediates Mammary Epithelial Cell Tumorigenesis through the ErbB4 Receptor
C. C. Lynch, T. Vargo-Gogola, M. D. Martin, B. Fingleton, H. C. Crawford, and L. M. Matrisian
Cancer Res. 67, 6760-6767 (15 July 2007)

HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80HER4
K. E. Strunk, C. Husted, L. C. Miraglia, M. Sandahl, W. A. Rearick, D. M. Hunter, H. S. Earp, and R. S. Muraoka-Cook
Cancer Res. 67, 6582-6590 (15 July 2007)

Bone Microenvironment and Androgen Status Modulate Subcellular Localization of ErbB3 in Prostate Cancer Cells
C.-J. Cheng, X.-c. Ye, F. Vakar-Lopez, J. Kim, S.-M. Tu, D.-T. Chen, N. M. Navone, L.-Y. Yu-Lee, S.-H. Lin, M. C-T. Hu et al.
Mol Cancer Res 5, 675-684 (1 July 2007)

Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family
S.-C. Hsu, and M.-C. Hung
J Biol Chem 282, 10432-10440 (6 April 2007)

Rac1 and a GTPase-activating protein, MgcRacGAP, are required for nuclear translocation of STAT transcription factors
T. Kawashima, Y. C. Bao, Y. Nomura, Y. Moon, Y. Tonozuka, Y. Minoshima, T. Hatori, A. Tsuchiya, M. Kiyono, T. Nosaka et al.
JCB 175, 937-946 (18 December 2006)

The Intracellular Domain of ErbB4 Induces Differentiation of Mammary Epithelial Cells
R. S. Muraoka-Cook, M. Sandahl, C. Husted, D. Hunter, L. Miraglia, S.-m. Feng, K. Elenius, and H. S. Earp
Mol. Biol. Cell 17, 4118-4129 (1 September 2006)

Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1
R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick, W. McCall, M. K. Sgagias et al.
Mol. Cell. Biol. 26, 6412-6424 (1 September 2006)

ErbB-4 s80 Intracellular Domain Abrogates ETO2-dependent Transcriptional Repression
B. Linggi, and G. Carpenter
J Biol Chem 281, 25373-25380 (1 September 2006)

Coregulation of Estrogen Receptor by ERBB4/HER4 Establishes a Growth-Promoting Autocrine Signal in Breast Tumor Cells
Y. Zhu, L. L. Sullivan, S. S. Nair, C. C. Williams, A. K. Pandey, L. Marrero, R. K. Vadlamudi, and F. E. Jones
Cancer Res. 66, 7991-7998 (15 August 2006)

Characterization of the Archaeal Thermophile Sulfolobus Turreted Icosahedral Virus Validates an Evolutionary Link among Double-Stranded DNA Viruses from All Domains of Life
W. S. A. Maaty, A. C. Ortmann, M. Dlakic, K. Schulstad, J. K. Hilmer, L. Liepold, B. Weidenheft, R. Khayat, T. Douglas, M. J. Young et al.
J. Virol. 80, 7625-7635 (1 August 2006)

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation
J. Anido, M. Scaltriti, J. J. Bech Serra, B. S. Josefat, F. Rojo Todo, J. Baselga, and J. Arribas
EMBO J. 25, 3234-3244 (12 July 2006)

The ERBB4/HER4 Intracellular Domain 4ICD Is a BH3-Only Protein Promoting Apoptosis of Breast Cancer Cells.
A. Naresh, W. Long, G. A. Vidal, W. C. Wimley, L. Marrero, C. I. Sartor, S. Tovey, T. G. Cooke, J. M.S. Bartlett, F. E. Jones et al.
Cancer Res. 66, 6412-6420 (15 June 2006)

Proteolytic Cleavage and Phosphorylation of a Tumor-associated ErbB4 Isoform Promote Ligand-independent Survival and Cancer Cell Growth
J. A. Maatta, M. Sundvall, T. T. Junttila, L. Peri, V. J. O. Laine, J. Isola, M. Egeblad, and K. Elenius
Mol. Biol. Cell 17, 67-79 (1 January 2006)

Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase
K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, U. Raju, L. Milas, D. J. Chen, R. Kehlbach, and H. P. Rodemann
J Biol Chem 280, 31182-31189 (2 September 2005)

ERBB4/HER4 Potentiates STAT5A Transcriptional Activity by Regulating Novel STAT5A Serine Phosphorylation Events
D. E. Clark, C. C. Williams, T. T. Duplessis, K. L. Moring, A. R. Notwick, W. Long, W. S. Lane, I. Beuvink, N. E. Hynes, F. E. Jones et al.
J Biol Chem 280, 24175-24180 (24 June 2005)

Presenilin-dependent {gamma}-Secretase Processing Regulates Multiple ERBB4/HER4 Activities
G. A. Vidal, A. Naresh, L. Marrero, and F. E. Jones
J Biol Chem 280, 19777-19783 (20 May 2005)

Growth Hormone Receptor Is a Target for Presenilin-dependent {gamma}-Secretase Cleavage
J. W. Cowan, X. Wang, R. Guan, K. He, J. Jiang, G. Baumann, R. A. Black, M. S. Wolfe, and S. J. Frank
J Biol Chem 280, 19331-19342 (13 May 2005)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882